Ranibizumab versus Verteporfin for Neovascular Age-Related Macular Degeneration
Top Cited Papers
Open Access
- 5 October 2006
- journal article
- research article
- Published by Massachusetts Medical Society in The New England Journal of Medicine
- Vol. 355 (14), 1432-1444
- https://doi.org/10.1056/nejmoa062655
Abstract
We compared ranibizumab — a recombinant, humanized, monoclonal antibody Fab that neutralizes all active forms of vascular endothelial growth factor A — with photodynamic therapy with verteporfin in the treatment of predominantly classic neovascular age-related macular degeneration.Keywords
This publication has 15 references indexed in Scilit:
- NEOVASCULAR AGE-RELATED MACULAR DEGENERATIONRetina, 2005
- GUIDELINES FOR USING VERTEPORFIN (VISUDYNE) IN PHOTODYNAMIC THERAPY FOR CHOROIDAL NEOVASCULARIZATION DUE TO AGE-RELATED MACULAR DEGENERATION AND OTHER CAUSES: UPDATERetina, 2005
- Racial Variations in Causes of Vision Loss in Nursing HomesAmerican Journal of Ophthalmology, 2004
- Morphometric Analysis of Angiograms of Exudative Lesions in Age-RelatedMacular DegenerationAmerican Journal of Ophthalmology, 2004
- Age-Related Macular Degeneration Is the Leading Cause of Blindness . . .JAMA, 2004
- Methods for a population-based study of the prevalence of and risk factors for age-related maculopathy and macular degeneration in elderly European populations: the EUREYE study.Ophthalmic Epidemiology, 2004
- Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization—verteporfin in photodynamic therapy report 2American Journal of Ophthalmology, 2001
- Photodynamic Therapy of Subfoveal Choroidal Neovascularization in Age-related Macular Degeneration With VerteporfinAmerican Journal of Ophthalmology, 1999
- Subfoveal Neovascular Lesions in Age-Related Macular DegenerationAmerican Journal of Ophthalmology, 1991
- Age-Related Macular Degeneration and Blindness due to Neovascular MaculopathyAmerican Journal of Ophthalmology, 1984